September 10, 2014

InVivo to acquire Pancosma

InVivo NSA, the French leader in animal nutrition and health, has reached an agreement to acquire Pancosma, Swiss‐based worldwide leader of physiological feed additives.

Hubert de Roquefeuil, chief executive officer of InVivo NSA, said, "Acquiring Pancosma allows InVivo NSA to become a major player in the specialty additive market while complementing our existing additive offering through our Neovia brand. This acquisition is fully in line with our strong investment in innovation (building of a world innovation centre in France) and illustrates our clear priority to build an innovative range of products adapted to evolving customer needs. By working closely with the existing Pancoma management we will now focus on enabling the synergies between our two businesses and create a new, efficient and dynamic additive business unit. This acquisition also reflects our strategy of development and balance between our five activities: complete feed, firm‐services and premixes, specialty additives, analysis laboratories, and animal health."

Daniel Kofel, chief executive officer of Pancosma and one of its major shareholders, added, "This acquisition will allow Pancosma to pursue and accelerate its development strategy while benefiting from InVivo's worldwide footprint and research and development capabilities. We at Pancosma and even more myself, are very pleased with what was achieved to date by our own means, and are looking forward to the next chapter of our development with even more cutting edge, practical and effective products and solutions for all our customers worldwide".

Financial details have not been disclosed. Subject to customary conditions, the transaction is expected to close before the end of the year.